The Online Investor
Stock Splits
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Stock Splits

By The Online Investor Staff, updated Thu., Oct. 8, 7:34 PM

Slide #3. Acasti Pharma Inc. (NASDAQ:ACST) 1 for 10 Reverse Split

Announced: 9/29/2015
Stock Split: 1 for 10
Record Date: 10/14/2015
Pay Date: 10/14/2015
ACST Optionable?: No

Acasti Pharma is a biopharmaceutical company engaged in the research, development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment and prevention of cardiovascular disorders. Co.'s products are derived from krill oil. Co.'s products include: CaPre® is for prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia; and Onemia™ is for cardiometabolic disorders treatments. Co. sells its products primarily in Canada and the U.S.
ACST Detailed Information Page & Split History »

Company Name:  Acasti Pharma Inc
Sector:  Diagnostics

Open the ACST Page at The Online Investor (in a new window) »

October 8, 2015    7:34 PM Eastern
Quotes delayed 20 minutes

Stock Splits | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.